Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ITCA 650 on Levora PK in Healthy Women
NCT02641990Phase 1Completed
- Sponsor
- Intarcia Therapeutics
- Start
- Dec 2015
- Primary completion
- Feb 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of exenatide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Intarcia Therapeutics. Primary endpoints: Area under the plasma concentration-time curve at steady state at 13 weeks and Maximum steady state plasma concentration at 13 weeks. Started Dec 2015; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02641990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02641990.